Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ± pamrevlumab (P) as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC).

被引：7

作者：

Picozzi, Vincent J.

Rocha, Flavio G.

Helton, Scott

Pishvaian, Michael J.

Jackson, Patrick G.

Mody, Kabir

Asbun, Horacio

Carney, Mairead

Etheridge, Tina

Neff, Thomas B.

Porter, Seth

Zhong, Ming

Valone, Frank

Kouchakji, Elias

Imperial, Joanne C.

Carrier, Ewa

机构：

[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA

[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA

[3] Mayo Clin, Jacksonville, FL 32224 USA

[4] FibroGen Inc, San Francisco, CA USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.4_suppl.365

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

365

引用

页数：2